Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer

Clinical trial NCT00401180 · COMPLETED

Trial details

NCT number: NCT00401180
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2002-06-01
Primary completion: 2008-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.